Xeris Biopharma Holdings Inc (XERS)

Depreciation & Amortization

$3.21M

Quarterly · Period ending: · USD

XERS logo

XERS Depreciation & Amortization

Latest reported$3.21M
XERS Quarterly Depreciation & Amortization ($38.00K → $3.21M)
High-resolution chart · PNG

XERS depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
3,210,000
3,210,000
3,046,000
3,189,000
3,164,000
3,143,000
3,133,000
3,124,000
3,154,000
3,214,000
3,259,000
3,357,000
3,363,000
3,181,000
3,503,000
3,071,000
3,062,000
3,032,000
899,000
323,000
320,000
337,000
446,000
383,000
318,000
320,000
380,000
339,000
225,000
134,000
174,000
5,000
78,000
63,000
54,000
52,000
33,000
38,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.